116 related articles for article (PubMed ID: 18491077)
1. Family 1 uridine-5'-diphosphate glucuronosyltransferases (UGT1A): from Gilbert's syndrome to genetic organization and variability.
Strassburg CP; Lankisch TO; Manns MP; Ehmer U
Arch Toxicol; 2008 Jul; 82(7):415-33. PubMed ID: 18491077
[TBL] [Abstract][Full Text] [Related]
2. Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype.
Lankisch TO; Moebius U; Wehmeier M; Behrens G; Manns MP; Schmidt RE; Strassburg CP
Hepatology; 2006 Nov; 44(5):1324-32. PubMed ID: 17058217
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of Gilbert's syndrome.
Strassburg CP
Pharmacogenomics; 2008 Jun; 9(6):703-15. PubMed ID: 18518849
[TBL] [Abstract][Full Text] [Related]
4. Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk.
Lankisch TO; Schulz C; Zwingers T; Erichsen TJ; Manns MP; Heinemann V; Strassburg CP
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):695-701. PubMed ID: 18349289
[TBL] [Abstract][Full Text] [Related]
5. Variability and function of family 1 uridine-5'-diphosphate glucuronosyltransferases (UGT1A).
Strassburg CP; Kalthoff S; Ehmer U
Crit Rev Clin Lab Sci; 2008; 45(6):485-530. PubMed ID: 19003600
[TBL] [Abstract][Full Text] [Related]
6. Gilbert-Meulengracht's syndrome and pharmacogenetics: is jaundice just the tip of the iceberg?
Strassburg CP
Drug Metab Rev; 2010 Feb; 42(1):168-81. PubMed ID: 20070246
[TBL] [Abstract][Full Text] [Related]
7. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.
Iyer L; King CD; Whitington PF; Green MD; Roy SK; Tephly TR; Coffman BL; Ratain MJ
J Clin Invest; 1998 Feb; 101(4):847-54. PubMed ID: 9466980
[TBL] [Abstract][Full Text] [Related]
8. Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatment.
Lankisch TO; Behrens G; Ehmer U; Möbius U; Rockstroh J; Wehmeier M; Kalthoff S; Freiberg N; Manns MP; Schmidt RE; Strassburg CP
J Hepatol; 2009 May; 50(5):1010-8. PubMed ID: 19303655
[TBL] [Abstract][Full Text] [Related]
9. Dual polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: a novel mechanism for hyperserotoninaemia in Gilbert's syndrome mimicking carcinoid syndrome?
Lee P; Jones G; Seibel MJ
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):337-40. PubMed ID: 17353700
[TBL] [Abstract][Full Text] [Related]
10. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.
Udomuksorn W; Elliot DJ; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
Pharmacogenet Genomics; 2007 Dec; 17(12):1017-29. PubMed ID: 18004206
[TBL] [Abstract][Full Text] [Related]
11. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing.
Gammal RS; Court MH; Haidar CE; Iwuchukwu OF; Gaur AH; Alvarellos M; Guillemette C; Lennox JL; Whirl-Carrillo M; Brummel SS; Ratain MJ; Klein TE; Schackman BR; Caudle KE; Haas DW;
Clin Pharmacol Ther; 2016 Apr; 99(4):363-9. PubMed ID: 26417955
[TBL] [Abstract][Full Text] [Related]
12. TATA-box mutant in the promoter of the uridine diphosphate glucuronosyltransferase gene in Italian patients with Gilbert's syndrome.
Sampietro M; Lupica L; Perrero L; Romano R; Molteni V; Fiorelli G
Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):194-8. PubMed ID: 9675658
[TBL] [Abstract][Full Text] [Related]
13. A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia.
Danoff TM; Campbell DA; McCarthy LC; Lewis KF; Repasch MH; Saunders AM; Spurr NK; Purvis IJ; Roses AD; Xu CF
Pharmacogenomics J; 2004; 4(1):49-53. PubMed ID: 14647407
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan.
Nagar S; Blanchard RL
Drug Metab Rev; 2006; 38(3):393-409. PubMed ID: 16877259
[TBL] [Abstract][Full Text] [Related]
15. Genetic interactions in the pathogenesis of neonatal hyperbilirubinemia: Gilbert's Syndrome and glucose-6-phosphate dehydrogenase deficiency.
Kaplan M
J Perinatol; 2001 Dec; 21 Suppl 1():S30-4; discussion S35-9. PubMed ID: 11803413
[TBL] [Abstract][Full Text] [Related]
16. Drug-mediated toxicity caused by genetic deficiency of UDP-glucuronosyltransferases.
Burchell B; Soars M; Monaghan G; Cassidy A; Smith D; Ethell B
Toxicol Lett; 2000 Mar; 112-113():333-40. PubMed ID: 10720749
[TBL] [Abstract][Full Text] [Related]
17. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.
Kadakol A; Ghosh SS; Sappal BS; Sharma G; Chowdhury JR; Chowdhury NR
Hum Mutat; 2000 Oct; 16(4):297-306. PubMed ID: 11013440
[TBL] [Abstract][Full Text] [Related]
18. Rapid allelic discrimination by TaqMan PCR for the detection of the Gilbert's syndrome marker UGT1A1*28.
Ehmer U; Lankisch TO; Erichsen TJ; Kalthoff S; Freiberg N; Wehmeier M; Manns MP; Strassburg CP
J Mol Diagn; 2008 Nov; 10(6):549-52. PubMed ID: 18832463
[TBL] [Abstract][Full Text] [Related]
19. The combination of new missense mutation with [A(TA)7TAA] dinucleotide repeat in UGT1A1 gene promoter causes Gilbert's syndrome.
D'Angelo R; Rinaldi C; Donato L; Nicocia G; Sidoti A
Ann Clin Lab Sci; 2015; 45(2):202-5. PubMed ID: 25887876
[TBL] [Abstract][Full Text] [Related]
20. The expression of uridine diphosphate glucuronosyltransferase gene is a major determinant of bilirubin level in heterozygous beta-thalassaemia and in glucose-6-phosphate dehydrogenase deficiency.
Sampietro M; Lupica L; Perrero L; Comino A; Martinez di Montemuros F; Cappellini MD; Fiorelli G
Br J Haematol; 1997 Nov; 99(2):437-9. PubMed ID: 9375769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
